MASI: Masimo Corporation - Summary | Jitta

Masimo Corporation

NASDAQ:MASI

End of day
Dec 14, 2018
Price
$107.04
Loss Chance
43.7%
7.50
Updated 2018Q3
last month
Nov 02, 2018
JITTA SCORE
64.58%Above Jitta Line
Jitta Ranking
52 / 795
United States
?
NASDAQ, NYSE
1,208 / 4,758
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (78)
Recent Business Performance (83)
Financial Strength (93)
Return to Shareholders (48)
Competitive Advantage (90)
Jitta Signs
Revenue and Earning
201220132014201520162017
Revenue8.619.5511.0312.4913.8415.46
Normalized Earning62.2764.2764.9976.99104.26131.62
EPS1.091.141.241.542.082.55
Consistent Growth in the past 5 years
Recent Business Performance
Earning per ShareQ1Q2Q3Q4
20180.880.841.08-
20171.010.870.690.01
20160.560.610.560.48
Earning Growth Last Year
Operating Margin
20132014201520162017
Operating Margin (%)16.2216.0617.8521.2724.73
Expansion
Debt Level
20132014201520162017
Net Profit (mill.)64.2764.9976.99104.26131.62
Long Term Debt (mill.)0.23125.15185.070.000.00
Low Long Term Debt
Share Repurchase
20132014201520162017
Common Shares (mill.)56.6252.5949.8850.1951.64
Every Year
Key Stats
Jitta Score
Jitta Line
7.50
64.58%
2.44
0.48%
Healthcare Equipment
COMPANY DESCRIPTION
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain’s electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation has a strategic partnership with NU Hospitals. The company was founded in 1989 and is headquartered in Irvine, California.